Johnson & Johnson is asking U.S. regulators for emergency approval of its Covid-19 vaccine
U.S. regulators on Thursday asked to approve the emergency use of their Covid-19 vaccine to pave the way for a potential third vaccine to be available in the U.S. within a few weeks.
J & J’s move follows last week’s publication of the results of an international clinical trial that found it to be a single one Shot of the vaccine was 66% effective in the prevention of moderate and severe Covid-19 disease. In the US portion of the study, the vaccine was 72% effective at preventing disease.
The addition of J & J’s vaccine could fuel a US mass vaccination campaign that has been troubled since it began in December. The first two vaccines, …